BC Innovations | Jun 20, 2013
Distillery Therapeutics

Indication: Cancer

Indication Target/marker/pathway Summary Licensing status Publication and contact information Cancer Cancer Eukaryotic translation elongation factor 2 kinase (EEF2K) Patient, mouse and cell culture studies suggest inhibiting EEF2K could help improve the efficacy of nutrient deprivation...
BC Innovations | Jun 23, 2011
Distillery Therapeutics

Indication: Neurology

Indication Target/marker/pathway Summary Licensing status Publication and contact information Neurology Depression Eukaryotic translation elongation factor 2 kinase (EEF2K) Mouse studies suggest decreasing EEF2K activity could help treat depression. In mice, two different EEF2K inhibitors decreased...
BioCentury | Apr 23, 2007
Tools & Techniques

High probability pathways

High probability pathways Pathway Genes in pathway (A) Pathway components [Ranking] (A) [5] Fibroblast growth factor (FGF) signaling MAP2K4; FGFR4; FGFR1; MAPK14; MAPK8; MAPK9; FGFR3; MAP3K6; MAP3K2; MAPK11; PRKCB1; RAF1; PRKCA; PRKCH; MAPK13; AKT3; PRKCE;...
Items per page:
1 - 3 of 3